Literature DB >> 15247303

Nicotine-induced up-regulation and desensitization of alpha4beta2 neuronal nicotinic receptors depend on subunit ratio.

Gretchen Y López-Hernández1, Javier Sánchez-Padilla, Alejandro Ortiz-Acevedo, José Lizardi-Ortiz, Janice Salas-Vincenty, Legier V Rojas, José A Lasalde-Dominicci.   

Abstract

Desensitization induced by chronic nicotine exposure has been hypothesized to trigger the up-regulation of the alpha4beta2 neuronal nicotinic acetylcholine receptor (nAChR) in the central nervous system. We studied the effect of acute and chronic nicotine exposure on the desensitization and up-regulation of different alpha4beta2 subunit ratios (1alpha:4beta, 2alpha:3beta, and 4alpha:1beta) expressed in Xenopus oocytes. The presence of alpha4 subunit in the oocyte plasmatic membrane increased linearly with the amount of alpha4 mRNA injected. nAChR function and expression were assessed during acute and after chronic nicotine exposure using a two-electrode voltage clamp and whole-mount immunofluorescence assay along with confocal imaging for the detection of the alpha4 subunit. The 2alpha4:3beta2 subunit ratio displayed the highest ACh sensitivity. Nicotine dose-response curves for the 1alpha4:4beta2 and 2alpha4:3beta2 subunit ratios displayed a biphasic behavior at concentrations ranging from 0.1 to 300 microm. A biphasic curve for 4alpha4:1beta2 was obtained at nicotine concentrations higher than 300 microm. The 1alpha4:4beta2 subunit ratio exhibited the lowest ACh- and nicotine-induced macroscopic current, whereas 4alpha4:1beta2 presented the largest currents at all agonist concentrations tested. Desensitization by acute nicotine exposure was more evident as the ratio of beta2:alpha4 subunits increased. All three alpha4beta2 subunit ratios displayed a reduced state of activation after chronic nicotine exposure. Chronic nicotine-induced up-regulation was obvious only for the 2alpha4: 3beta2 subunit ratio. Our data suggest that the subunit ratio of alpha4beta2 determines the functional state of activation, desensitization, and up-regulation of this neuronal nAChR. We propose that independent structural sites regulate alpha4beta2 receptor activation and desensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247303     DOI: 10.1074/jbc.M403537200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.

Authors:  Andrew M Smith; Marharyta Pivavarchyk; Thomas E Wooters; Zhenfa Zhang; Guangrong Zheng; J Michael McIntosh; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2010-03-25       Impact factor: 5.858

2.  Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).

Authors:  Linda P Dwoskin; B Matthew Joyce; Guangrong Zheng; Nichole M Neugebauer; Vamshi K Manda; Paul Lockman; Roger L Papke; Michael T Bardo; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2007-07-21       Impact factor: 5.858

3.  Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.

Authors:  A-L Carbone; M Moroni; P-J Groot-Kormelink; I Bermudez
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

4.  Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.

Authors:  Cheng Xiao; Julie M Miwa; Brandon J Henderson; Ying Wang; Purnima Deshpande; Sheri L McKinney; Henry A Lester
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

5.  Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.

Authors:  Loredana Riganti; Cosetta Matteoni; Silvia Di Angelantonio; Andrea Nistri; Annalisa Gaimarri; Fabio Sparatore; Caterina Canu-Boido; Francesco Clementi; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

6.  Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.

Authors:  Sangeetha P Sumithran; Peter A Crooks; Rui Xu; Jun Zhu; Agripina G Deaciuc; Lincoln H Wilkins; Linda P Dwoskin
Journal:  AAPS J       Date:  2005-08-29       Impact factor: 4.009

7.  bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.

Authors:  Thomas E Wooters; Andrew M Smith; Marharyta Pivavarchyk; Kiran B Siripurapu; J Michael McIntosh; Zhenfa Zhang; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

8.  Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.

Authors:  Jonathan D Raybuck; George S Portugal; Caryn Lerman; Thomas J Gould
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

9.  Choline promotes nicotinic receptor alpha4 + beta2 up-regulation.

Authors:  Lorise C Gahring; Gustavo A Vasquez-Opazo; Scott W Rogers
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

10.  Nicotine activates and up-regulates nicotinic acetylcholine receptors in bronchial epithelial cells.

Authors:  Xiao Wen Fu; Jon Lindstrom; Eliot R Spindel
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.